Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 985 products on this category.

Product data	Purity	Price range	Estimated delivery
Carfilzomib Impurity 39 REF: 4Z-C-121042CAS: 875309-82-3	- - -	To inquire	Fri 27 Dec 24
N-Nitroso Enzalutamide Impurity 7 REF: 4Z-E-068069	- - -	To inquire	Fri 27 Dec 24
Carfilzomib Impurity 49 REF: 4Z-C-121052	- - -	To inquire	Fri 27 Dec 24
Fulvestrant R Enantiomer REF: 4Z-F-3137CAS: 1316849-17-8	- - -	To inquire	Fri 27 Dec 24
Lenvatinib Impurity 21 REF: 4Z-L-124026CAS: 253801-34-2	- - -	To inquire	Fri 27 Dec 24
Palbociclib Impurity 74 REF: 4Z-P-196081CAS: 2399424-46-3	- - -	To inquire	Fri 27 Dec 24
Abiraterone Impurity 12 REF: 4Z-A-8249CAS: 165334-72-5	- - -	To inquire	Fri 27 Dec 24
9-Bromononanol REF: 4Z-F-3121CAS: 55362-80-6	- - -	To inquire	Fri 27 Dec 24
Gimeracil Impurity 1 REF: 4Z-G-047001	- - -	To inquire	Fri 27 Dec 24
Olaparib Impurity 66 REF: 4Z-O-032071CAS: 6940-49-4	- - -	To inquire	Fri 27 Dec 24
Enzalutamide Impurity 52 REF: 4Z-E-068065CAS: 1067225-60-8	- - -	To inquire	Fri 27 Dec 24
Nintedanib Impurity 90 REF: 4Z-N-066103	- - -	To inquire	Fri 27 Dec 24
Fulvestrant Impurity 27 REF: 4Z-F-3145CAS: 1107606-69-8	- - -	To inquire	Fri 27 Dec 24
Lenvatinib Impurity 3 REF: 4Z-L-124006	- - -	To inquire	Fri 27 Dec 24
Fulvestrant Impurity 28 REF: 4Z-F-3146	- - -	To inquire	Fri 27 Dec 24
Olaparib Impurity 52 REF: 4Z-O-032057	- - -	To inquire	Fri 27 Dec 24
Enzalutamide Impurity 7 REF: 4Z-E-068020CAS: 1802242-46-1	- - -	To inquire	Fri 27 Dec 24
Gimeracil Impurity 23 REF: 4Z-G-047028CAS: 63910-63-4	- - -	To inquire	Fri 27 Dec 24
Olaparib Impurity 46 REF: 4Z-O-032051	- - -	To inquire	Fri 27 Dec 24
Carfilzomib Impurity 9 REF: 4Z-C-121012CAS: 868540-22-1	- - -	To inquire	Fri 27 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

Carfilzomib Impurity 39

Ref: 4Z-C-121042

N-Nitroso Enzalutamide Impurity 7

Ref: 4Z-E-068069

Carfilzomib Impurity 49

Ref: 4Z-C-121052

Fulvestrant R Enantiomer

Ref: 4Z-F-3137

Lenvatinib Impurity 21

Ref: 4Z-L-124026

Palbociclib Impurity 74

Ref: 4Z-P-196081

Abiraterone Impurity 12

Ref: 4Z-A-8249

9-Bromononanol

Ref: 4Z-F-3121

Gimeracil Impurity 1

Ref: 4Z-G-047001

Olaparib Impurity 66

Ref: 4Z-O-032071

Enzalutamide Impurity 52

Ref: 4Z-E-068065

Nintedanib Impurity 90

Ref: 4Z-N-066103

Fulvestrant Impurity 27

Ref: 4Z-F-3145

Lenvatinib Impurity 3

Ref: 4Z-L-124006

Fulvestrant Impurity 28

Ref: 4Z-F-3146

Olaparib Impurity 52

Ref: 4Z-O-032057

Enzalutamide Impurity 7

Ref: 4Z-E-068020

Gimeracil Impurity 23

Ref: 4Z-G-047028

Olaparib Impurity 46

Ref: 4Z-O-032051

Carfilzomib Impurity 9

Ref: 4Z-C-121012